Barely Significant
← all excerpts

Efficacy and Safety of a Drinkable Nutraceutical in Premenopausal Women with Telogen Effluvium: A 6-Month, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study.

Dermatol Ther (Heidelb) · 2026 · PMC12872997 · PMID 41288927

1
hedged sentence
closest p
boldest claim

The sentences

a favorable trendno p-value reported
This shift reflects a favorable trend toward normalization of the hair growth cycle, suggesting that this nutraceutical effectively supports hair follicle cycling homeostasis by prolonging anagen duration and reducing the premature transition into the catagen and telogen phases—an important objective in managing TE [ 14 , 60 ].

also in 993 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.